Attenuated live vaccines are expected to emerge as the dominant vaccine type segment over the forecast period
Attenuated live vaccines segment is the largest segment among the vaccine type segments, which was estimated to create close to US$ 90 Mn, or more than 30% share of the total market in 2016. By the end of 2026, attenuated live vaccines segment is projected to reach more than US$ 150 Mn, expanding at a CAGR of 5.8% over the forecast period. Greater adoption of live attenuated vaccines is expected to contribute to the attractive absolute $ opportunity of the segment. Attenuated live vaccines segment is expected to be the most lucrative in the MEA veterinary vaccines market with a market attractiveness index of 2.0.
Rising incidence of food borne and zoonotic diseases in MEA countries likely to fuel the demand for attenuated live vaccines
Rising incidence of food borne and zoonotic diseases in MEA countries is fuelling the demand in the attenuated live vaccines segment in the region. As the pattern of veterinary treatment is shifting from curative/reactive to preventive, the cost of a preventive treatment is much smaller and has far less side effects than reactive treatments that often lead to mass slaughter. This is the precise reason behind driving the growth of the attenuated live vaccines segment in the MEA region. Rebound of economic prosperity in MEA markets is expected to contribute towards increased demand for processed healthy meat products. This demands effective vaccination of livestock, especially in major animal farming and meat producing nations with a diversified herd in the region such as Sudan, Turkey, Egypt and KSA. Rising per capita disposable income levels are largely contributing to the rise in demand for processed food items. This is expected to drive the growth in demand for attenuated live vaccines in the poultry and livestock segments.
Veterinary Vaccines Market: Greater Adoption of Live Attenuated Vaccines Likely to be Witnessed Throughout the Forecast Period: Middle East Industry Analysis & Opportunity Assessment, 2016 - 2026Buy Now
Custom Market Research Services
xploreMR offers custom market reserch services that help clients to get information on their business scenario required where syndicated solutions are not enough
Why Choose XploreMR
Our analysts go above and beyond to answer your specific queries. We are with you throughout the entire journey – from initial discussion to post-purchase.
Country-wise Analysis & Forecasting
As we track markets at country-level, we are able to offer hard-to-find market intelligence in both developed and emerging countries.
High Quality At Competitive Pricing
We believe high quality market research shouldn’t be out of reach for businesses. Our competitively-priced market research reports ensure businesses of all sizes have access to quality information
Respiratory Virus Vaccines Market Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2020 to 2030
Respiratory Virus Vaccines Market - Scope of the Report A recent study by XploreMR on the respiratory virus vaccines market offers a 10-year forecast for 2020 and 2030. The study analyzes crucial tre ...
Global Market Study on Autogenous Vaccines: Increasing Funding for Animal Disease Eradication and Immunization Propelling Growth
Autogenous Vaccines Market: Scope of the Report XploreMR recently published a study on the global autogenous vaccines market. The study provides detailed assessment on key market dynamics, inclu ...